TUMOR-ASSOCIATED DNA MOVEMENT
TUMOR-ASSOCIATED DNA MOVEMENT
批准号:
3173935
负责人:
ERIK SELSING
金额:
$9.87万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-12-01 至 1986-11-30
中文摘要
越来越多的证据表明,肿瘤的发生可能需要特定的基因
一些事件,其中一些可能涉及染色体易位。我们有
研究发现,在许多小鼠B细胞肿瘤中,一段DNA经常
移位(肿瘤相关重组DNA或TAR DNA)。在两个B细胞中
品系,TAR DNA已经从潜在的活性重组到下游
免疫球蛋白基因启动子。涉及TAR DNA的重组不是
与c-myc基因易位有关的基因也见于许多B细胞肿瘤。焦油
DNA重组在Lambda的生产中被发现得更频繁
B细胞系比产生kappa的肿瘤中更多。可能是因为焦油
重组是B细胞发育过程中的调节事件
成熟。我们将研究TAR DNA重组以阐明
B细胞肿瘤染色体重组的分子机制
并确定这些重组对肿瘤的发生是否重要。
DNA运动可能在转化过程中发挥重要作用,因为
在正常的发育和进化中也是如此。(D)
英文摘要
Increasing evidence suggests that oncogenesis may require specific genetic
events, some of which may involve chromosomal translocations. We have
found that, in many murine B-cell tumors, a segment of DNA is frequently
translocated (tumor-associated recombining DNA or tar DNA). In two B-cell
lines, tar DNA has recombined downstream from potentially active
immunoglobulin gene promoters. Recombinations involving tar DNA are not
related to c-myc gene translocations also seen in many B-cell tumors. Tar
DNA recombinations are found much more frequently in lambda-producing
B-cell lines than in kappa-producing tumors. It may be that tar
recombination is a developmentally regulated event during B-cell
maturation. We will investigate tar DNA recombination to elucidate the
molecular mechanisms underlying chromosomal recombinations in B-cell tumors
and to determine if these recombinations are important for tumorigenesis.
DNA movement may play a significant role in the transformation process as
well as in normal development and evolution. (D)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Testing a role for activation-induced deaminase in Omenns syndrome B-cell autoimm
-
批准号:8304205
-
项目类别:
-
资助金额:$8.25万
-
财政年份:2011
-
负责人:ERIK SELSING
-
依托单位:
Testing a role for activation-induced deaminase in Omenns syndrome B-cell autoimm
-
批准号:8176094
-
项目类别:
-
资助金额:$8.25万
-
财政年份:2011
-
负责人:ERIK SELSING
-
依托单位:
Transgenic Mice for Sensing Bioweapons
-
批准号:6962753
-
项目类别:
-
资助金额:$18.06万
-
财政年份:2005
-
负责人:ERIK SELSING
-
依托单位:
Transgenic Mice for Sensing Bioweapons
-
批准号:7140341
-
项目类别:
-
资助金额:$20.07万
-
财政年份:2005
-
负责人:ERIK SELSING
-
依托单位:
FUNCTIONS OF ANTIBODY SWITCH REGIONS
-
批准号:6225696
-
项目类别:
-
资助金额:$20.88万
-
财政年份:2000
-
负责人:ERIK SELSING
-
依托单位:
FUNCTIONS OF ANTIBODY SWITCH REGIONS
-
批准号:6475490
-
项目类别:
-
资助金额:$20.88万
-
财政年份:2000
-
负责人:ERIK SELSING
-
依托单位:
FUNCTIONS OF ANTIBODY SWITCH REGIONS
-
批准号:6624520
-
项目类别:
-
资助金额:$20.88万
-
财政年份:2000
-
负责人:ERIK SELSING
-
依托单位:
SOMATIC MUTATION OF AN ANTIBODY TRANSGENE
-
批准号:2887498
-
项目类别:
-
资助金额:$17.6万
-
财政年份:1997
-
负责人:ERIK SELSING
-
依托单位:
SOMATIC MUTATION OF AN ANTIBODY TRANSGENE
-
批准号:2673042
-
项目类别:
-
资助金额:$17.09万
-
财政年份:1997
-
负责人:ERIK SELSING
-
依托单位:
SOMATIC MUTATION OF AN ANTIBODY TRANSGENE
-
批准号:2382590
-
项目类别:
-
资助金额:$16.28万
-
财政年份:1997
-
负责人:ERIK SELSING
-
依托单位:
IMMUNITY IN TRANSGENIC MICE
-
批准号:2062598
-
项目类别:
-
资助金额:$24.53万
-
财政年份:1987
-
负责人:ERIK SELSING
-
依托单位:
IMMUNITY IN TRANSGENIC MICE
-
批准号:3137476
-
项目类别:
-
资助金额:$11.14万
-
财政年份:1987
-
负责人:ERIK SELSING
-
依托单位:
IMMUNITY IN TRANSGENIC MICE
-
批准号:3137480
-
项目类别:
-
资助金额:$12.6万
-
财政年份:1987
-
负责人:ERIK SELSING
-
依托单位:
Immunity in Transgenic Mice
-
批准号:6631735
-
项目类别:
-
资助金额:$31.7万
-
财政年份:1987
-
负责人:ERIK SELSING
-
依托单位:
IMMUNITY IN TRANSGENIC MICE
-
批准号:2671884
-
项目类别:
-
资助金额:$28.69万
-
财政年份:1987
-
负责人:ERIK SELSING
-
依托单位:
IMMUNITY IN TRANSGENIC MICE
-
批准号:3137478
-
项目类别:
-
资助金额:$23.84万
-
财政年份:1987
-
负责人:ERIK SELSING
-
依托单位:
IMMUNITY IN TRANSGENIC MICE
-
批准号:3137479
-
项目类别:
-
资助金额:$12.66万
-
财政年份:1987
-
负责人:ERIK SELSING
-
依托单位:
Immunity in Transgenic Mice
-
批准号:6510367
-
项目类别:
-
资助金额:$30.12万
-
财政年份:1987
-
负责人:ERIK SELSING
-
依托单位:
IMMUNITY IN TRANSGENIC MICE
-
批准号:3137477
-
项目类别:
-
资助金额:$20.99万
-
财政年份:1987
-
负责人:ERIK SELSING
-
依托单位:
Immunity in Transgenic Mice
-
批准号:7033545
-
项目类别:
-
资助金额:$40.88万
-
财政年份:1987
-
负责人:ERIK SELSING
-
依托单位:
海外基金